Top mergers and acquisitions in Switzerland in February 2026
Every verified merger and acquisition involving Switzerland in this period, ranked by disclosed value. Updated every morning.
We tracked 5 deals involving Switzerland in February 2026, 2 of them with a disclosed value, worth $2.7bn in total. The largest was CVC Capital Partners's $2.6bn deal for dsm-firmenich Animal Nutrition & Health, ahead of Alkem Laboratories Ltd (Alkem MedTech) and Occlutech Holding AG (majority stake) at $118m.
Top mergers and acquisitions in Switzerland in February 2026
- 19 FebCVC Capital Partners → dsm-firmenich Animal Nutrition & HealthCVC agrees €2.2bn carve-out of dsm-firmenich animal nutrition armChemicals / Animal nutritionAgreed$2.6bn
- 213 FebAlkem Laboratories Ltd (Alkem MedTech) → Occlutech Holding AG (majority stake)Alkem buys majority of Swiss heart-implant maker Occlutech for €99.4mHealthcare / Medical devicesCompleted$118m
- 324 FebEPC Groupe → SSE Group civil explosives and drilling & blasting businessesEPC and SSE call off civil explosives combinationChemicals / Civil explosivesTerminatedUndisclosed
- 425 FebOne River Asset Management → LGT Capital Partners Quantitative Investment Solutions unitOne River agrees to buy LGT Capital Partners' quant unitFinancials / Asset managementAgreedUndisclosed
- 527 FebMitsubishi Heavy Industries Compressor Corporation → AST Turbo AGMitsubishi Heavy Industries buys Swiss turbine service firm AST TurboIndustrials / Industrial servicesCompletedUndisclosed